BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fatty acid metabolic process
,
HIV infection
,
Intestine
,
Rosiglitazone
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ND4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Heart
Thalamus lateral nuclei
Heart ventricle
Bladder
Colon mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bovine respiratory syncytial virus disease
Viremia
COVID-19
Transplanted organ rejection
Viral disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
S-Adenosylmethionine
GRN protein, human
granulin precursor protein
Tdgf1 protein, mouse
Nodal protein, mouse
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CDHR2
LRPPRC
PPM1D
PABPN1
SLC7A5
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Genetic diversity and phylogeography of Phlebotomus argentipes (Diptera: Psychodidae, Phlebotominae)…
Construction and detection of a novel type of recombinant human rAAV2/2-ND4.
Mitochondrial Diabetes Is Associated with the ND4 G11696A Mutation.
Next-generation sequencing of mitochondrial targeted AAV transfer of human ND4 in mice.
Variation in mitochondrial NADH dehydrogenase subunit 5 and NADH dehydrogenase subunit 4 genes in th…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to th…
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due …
Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation…
Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic Neuropathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ